Mycoplasma pneumoniae (MP) is, considered to affect rarely children less than 5 yrts of age. This study was performed to describe the epidemiology and the clinical features of MP lower respiratory tract infection (LRTI) in children, presenting to a tertiary children hospital.
Introduction
Mycoplasmas, the smallest known free-living forms, have been associated with a variety of clinical manifestations, including those involving the respiratory tract which are related to Mycoplasma pneumoniae (M. pneumoniae). 1, 2 Indeed, M. pneumoniae is a significant cause of respiratory tract infections in humans and an important pathogen in acute respiratory illnesses in children and in adults, accounting for as many as 20e40% of all cases of community-acquired pneumonia. 2e4 However, as direct invasion of the different tissues or, indirectly, as a result of the host immune system reaction to infection, M. pneumoniae can also cause extrapulmonary disorders affecting the skin, the gastrointestinal tract, the cardiovascular, musculoskeletal, nervous and renal systems. 1e4 Current concepts recognize that community-acquired epidemics due to M. pneumoniae infection affect mainly school-aged children and young adults. 2e5 The assumption that M. pneumoniae disease is rare in preschool-aged children may probably precluded most physicians from considering it in the differential diagnosis in this age population. However, in the last decades studies indicated that M. pneumoniae infection may be frequent in children less than 5 yrs old, and suggested differences in its clinical presentation between younger and older patients. 6e9 Evaluating paediatric patients with community-acquired pneumonia in Finland, it was found that out of the children with a confirmed diagnoses of M. pneumoniae infection, 21% were <5 yrs of age, 6 while during an epidemic outbreak of M. pneumoniae infection in Catalonia, rate in children <5 yrs old was 18% versus 8.2% in those 5e14 yrs old. 7 In contrast, evaluating the prevalence of M. pneumoniae in children in Turkey, detection of serum specific IgG was positive only in children >2 yrs old, with a sudden increase in seropositivity at 7 yrs of age. 8 Finally, the age group most commonly affected by M. pneumoniae infection in children presenting to a tertiary children's hospital in Australia was 5e9 yrs, followed by children of 1e5 yrs old. 9 Even though the commonest presentation in this study population was with cough and fever, coryza, diarrhoea, vomiting, tachypnoea and recession were significantly more common in children less than 5 yrs than in children 5e15 yrs. 9 Due to the non homogeneous and limited data in the literature an 11-month-longitudinal study was performed to evaluate the epidemiology, the clinical and roentgenographic features and the laboratory results of M. pneumoniae lower respiratory tract infection (LRTI) in children, presenting to a tertiary children's hospital, aimed to evaluate possible age-related difference in the presenting clinical features.
Materials and methods

Study population
Eight hundred and eighty-six consecutive children with lower respiratory tract infection (LRTSI) admitted to the Gaslini Institute in Genoa were evaluated prospectively over a an 11-month period (October 1, 2005eAugust 31, 2006 . Children were eligible for enrolment if they had: (a) clinical (fever, persistent cough, tachypnoea, chest retractions, or abnormal auscultatory findings) and/or radiologic evidence of LRTI (presence of consolidation, interstitial changes, pleural effusion or mediastinal lymphadenopathy) and (b) positive PCR and elevated IgM at admission or at follow-up or a fourfold increase in IgG.
For this research, fever was defined as a recorded temperature ! 38.0 C on admission.
Children were excluded if they had severe concomitant disease such as kidney or liver disease, neoplasms, primary ciliary dyskinesia, cystic fibrosis, congenital or acquired immunodeficiency or immunosuppression, due to systemic disorders, or treatments, cardiovascular disease or malabsorption syndromes.
According to the clinical findings, children were diagnosed as: (a) acute bronchitis, with or without wheezing, if they had cough and rhonchi, with a normal chest radiograph, when performed; (b) wheezy bronchitis if they had cough, and/or dyspnoea with expiratory rales and/or wheezes unrelated to any known specific sensitization, with a normal chest radiograph or hyperinflation, when performed; (c) pneumonia if they had diffuse or lobar pulmonary infiltration evident on the chest radiograph; (d) bronchiolitis when wheezing and/or dyspnoea and/or tachypnoea, and roentgenographic evidence of hyperinflation of the lung with or without areas of collapse were present. 5, 10, 11 
Patient evaluation
Demographic and clinical data were collected uniformly from all children and laboratory specimens were obtained. These included nasal and throat swab specimens and blood samples cultured and processed in accordance with standard microbiological procedures for bacteria and the most common respiratory viruses. Blood samples were evaluated also for total cells and differential counts and serum level of C-reactive protein (CRP). Chest X-ray were was performed when clinically indicated. Diagnosis of M. pneumoniae infection was based on real-time PCR by targeting the P1 cytoadhesin type 1 and 2 gene of the M. pneumoniae genome using DNA extracted from oropharyngeal swabs. The swabs, stored in 1 ml of sterile PBS, were centrifuged at 14,000 rpm for 10 min and the pellets were resuspended in 200 ml of PBS and processed to extract DNA with QIAamp DNA Mini kit (QIAGESPAN S.p.A., Milano, Italy). The PCR reaction was performed on samples and on positive and negative controls as follows: the 72 bp fragment of the target gene was amplified using Mycpn P1-F forward primer (5 0 -GCC GCA AAG ATG AAY GAC G-3 0 ) and Mycpn P1-F reverse primer (5 0 -TCC TTC CCC ATC TAA CAG TTC AG-3 0 ) in combination with a TaqMan probe (5 0 FAM-TTG ATG GTA TTG TAC GCA CCC CAC TCG-3 0 TAMRA). Reaction was carried out with the Rotor Gene 3000 (Corbett Research, Diatech SRL, Italy) instrument. Each reaction mixture was performed in 25 ml containing template DNA, 1Â Platinum Quantitative PCR SuperMix-UDG Master Mix (Invitrogen, Milano, Italy), primers at 300 nM and probe at 200 nM. PCR cycling conditions were 2 min at 50 C, 2 min at 95 C and then 40 cycles of denaturation at 95 C for 20 s and annealing/extension 58 C for 60 s. 12e15 PCR results were available within 3 h. Acute IgM serology and/or elevated IgG titers in serum were also evaluated using a commercial test kit (Serion ELISA classic M. pneumoniae IgG/IgM, Institut Vir-ion\Serion GmbH, Friedrich-Bergius-Ring 19 97076 Würzburg, Germany). IgM and IgG levels for M. pneumoniae were also re-evaluated 3e4 to weeks later, in ''convalescence phase'', in patients with IgM < 30 U/ml and IgG < 17 U/ml.
The Institutional Ethical Committee of the Gaslini Institute approved the protocol. Signed informed parental consent were obtained.
Data analysis
Descriptive statistics were performed and reported in terms of absolute frequencies or percentages for qualitative data, in terms of means or medians with standard deviations (SD) or lower and upper quartiles in parenthesis for quantitative data. Quantitative variables such as white blood cells, platelet count and oxygen saturation less in room air were dichotomized on the basis of the their 'normal' values related to different ages. Comparison of quantitative variables among the three age groups of patients was made by ANOVA or KruskaleWallis test when appropriate. Comparison of frequency distribution was made by means of the Chi-Square test, and the Fisher's exact test was used in case of at least one expected frequency less than 5. All tests were two-tailed. Data were analysed using STATA version 7.0. A difference of P < 0.05 was considered to be statistically significant.
Results
Patients
Out of the eight hundred and eighty-six children admitted for an acute respiratory disease, 102 (12%) had a positive PCR for M. pneumoniae and, of those, 63 (62.2%) had also antigen-specific IgM and/or antigen-specific IgG levels in the serum. The male to female ratio of the patients with M. pneumoniae infection (PCR positive) was 1.17 and the mean age was 6.20 (3.81) yrs, ranging from 1 month to 13.5 yrs. Subdividing the M. pneumoniae positive children into 3 age groups, we found 21 (20.6%) young adolescent (i.e. !10e 14 yrs old), 42 (41.2%) school-aged children (i.e. >5e<10 yr) and 39 (38.2%) preschool-aged children (i.e. <5 yr). In this latter group, 22 (21.57%) children were less than 24 months (Fig. 1 ). The mean hospital stay was 4.82 (2.68) while the treatment duration with macrolides (chlarytromicin) was 11 AE 2 days.
Infection associated with M. pneumoniae occurred throughout the year, with 9 cases seen in most of the months. A peak was observed in June with a total of 23 (22.5%) cases seen during that period of the year (Fig. 2) .
Clinical presentation
Respiratory manifestations
The predominant onset symptoms were fever, [75 (73.5%)] and cough [43 (42.1%)]. Usually children reported the presence of persistent cough and fever, insensitive to beta-lactam antibiotics treatment. Cough was most frequently described as moist, although a dry, non-productive cough was also described. In some patients, symptoms began abruptly with respiratory distress, with an oxygen saturation less than 95% in room air, detected in 36 (35.3%) children; none of these patients required assisted ventilation. Dyspnoea was detected in 28 children (27.5%). On physical examination children were found to have mild-tomoderate expiratory wheeze and inspiratory and expiratory crackles.
Although the respiratory system was always predominantly involved, twenty patients also had significant gastroenterologic manifestations, such as vomiting [15 (14. 7%)] and diarrhoea [5 (4.9%)]. Two patients had a history of diffuse macular rash during illness involving the trunk and limbs and 2 patients of arthralgia while none presented haemolytic anaemia or symptoms suggesting nervous system involvement. Comparison among the three age groups, showed that dyspnoea, upper respiratory tract involvement, diarrhoea and vomiting were more common in the preschool-aged group (38.46%) as compared to the older groups (14.29% in school-aged children and 28.57% in young adolescents) (p Z 0.047). Similarly, we also observed that dyspnoea was more frequently diagnosed in preschoolaged children than in older children (Table 1) . Among the 102 patients evaluated, 6 (5.89%) had a previous diagnosis of asthma and 42 (41.18%) had previous history of upper and/or lower respiratory tract infections.
Investigations
A chest X-ray was performed in 81 of the 102 children. Seventy-six roentgenograms (93.8%) were reported as abnormal. Consolidation was the commonest finding, in 62 (76.5%) of the radiological abnormalities recorded, more often unilateral (53.09%) than bilateral (23.46%). Interstitial changes were reported in 14 patients (17.28%), and pleural effusion in 6 (7.4%). Mediastinal lymphadenopathy was never detected.
On the basis of both clinical and roentgenographic findings, a diagnosis of pneumonia with or without pleural effusion was done in 77 children, acute bronchitis in four, wheezy bronchitis in 18 and bronchiolitis in three.
Interstitial changes were more frequently reported in preschool-aged group than in school-aged or young adolescent groups (p < 0.0001, Table 1 ) whereas consolidations were more frequently reported in the 5e<10 yrs and !10 yrs groups than in <5 yrs group (p Z 0.004) ( Table 1) .
A full blood count was available in all patients. Total WBC count varied from 3.33 Â 10 3 to 26.56 Â 10 3 cells/mm 3 (mean 11.22 Â 10 3 cells/mm 3 ). Normal leukocyte total and differential count, was found in 82 patients (81%). Twenty children (19%) had leukocytosis. Thrombocytosis, defined as a platelet count more than 400 Â 10 9 /L, was documented in 33 (32.35%) patients. None of the patients evaluated had haemoglobin of less than 8 g/L and/or haemolytic anaemia secondary to M. pneumoniae infection.
Comparison of laboratory tests results among different age groups (Table 2) showed that children in the <5 yrs group had a higher number of lymphocytes (p < 0.0001) and monocytes (p Z 0.009). Also thrombocytosis was more frequent in preschool-aged (p Z 0.013). Serum C-reactive protein was also measured in all patients: 77% had an increased level of more than 0.5 g/L (minimum-maximum values: 0.68-22.21 mg/dl, median: 1.55 mg/dl). IgG and IgM antibodies against M. pneumoniae were quantitatively detected in 83 serum samples by using the ELISA. test were analyzed Elevated serum levels of M. pneumoniae-specific IgM and/ or IgG, confirming a diagnosis of M. pneumoniae infection, were detected in 38 (45.8%) on admission (Table 3 ). In patients with negative sierology, a ''convalescent'' sample was obtained and showed in all patients an elevation of M. pneumoniae-specific IgM and/or IgG levels (>30 U/ml and >17 U/ml, respectively) consistent with a recent M. pneumoniae infection.
Co-infections with RSV occurred in 4 children younger than 2 yrs.
Characteristics of M. pneumoniae infection in patients less than 1 yr of age
In the 2 yrs group, 8 infants had 8 months of age, (two 1 month old, one 4 months old, two 5, one 6 and two 8 months old, respectively) and, in addition to a positive PCR for M. pneumoniae, three had also detectable antigen-specific IgM and IgG in serum. Transcutaneous oxygen saturation in room air was <95% only in two patients and, in addition to respiratory symptoms, three presented vomiting. Chest X-ray was reported as abnormal in all but one infant (6 had interstitial changes and two parenchymal consolidations) while co-infections with RSV occurred in three cases (Table 4 ). 
Discussion
Evaluating children admitted for lower respiratory tract infection (LRTI) over an 11-month period, we found that approximately 12% had a positive PCR for M. pneumoniae and of these, 39 were less than 5 yrs old, including 8 infants younger than 8 months of age. In all children with M. pneumoniae infection the commonest symptoms were cough and fever, while chest X-ray demonstrated predominantly consolidations (76% of the radiological abnormalities recorded), interstitial changes, and pleural effusions being reported, respectively, in 17 and 7%. Differences in the clinical presentation of M. pneumoniae infection were detected among younger and older patients. In children less than 5 yrs old tachypnoea, upper respiratory tract involvement, diarrhoea and vomiting were more common (p Z 0.047), interstitial changes on chest X-rays were more frequently reported and laboratory test showed higher number of lymphocytes and monocytes. Thrombocytosis and co-infections with RSV were also more common in the younger than in the older patients. M. pneumoniae infections have been traditionally thought to occur in school-aged children, although recent studies indicated that it may be less rare than believed in children less than 5 yrs old. 6, 8, 9, 13 Indeed, reports from different countries indicate that the incidence of M. pneumoniae is highest, in school-aged children, but also in children 1e5 yrs of age, but with infants less than 1 yr old were rarely affected. 6, 8, 9, 13, 14 The results here reported are only partially in agreement with the other studies since out of the 102 children with M. pneumoniae infection, 42 were between 5 and 10 yrs of age and 21 between 10 and 14 yrs of age, but 39 were less than 5 yrs old, including 8 young infants. Indeed, in the study performed in Finland, but only on patients with community-acquired pneumonia, only 21% of the children with M. pneumoniae infection were <5 yrs of age, a percentage similar to the 18% reported during the epidemic outbreak in Catalonia, 7 while in the Australian study, out of the children presenting to a tertiary children's hospital with M. pneumoniae infection, 39% were less than 5 yrs old. 9 The relatively low incidence in adolescents, found in the present but also in other reports, 9 may be probably explained by the observation that among persons who have had M. pneumoniae infection, rates of subsequent relapse are low because immunity appears to increase progressively with age. 14 Unlike endemic disease, which may not demonstrate marked seasonal occurrence, it is generally though that outbreaks of M. pneumoniae infection in countries with temperate climates, such as Italy, tend to occur in the summer or early fall, when the occurrence of other respiratory pathogens is generally lower. 15 Although we have observed a peak incidence in June, with a total of 23 cases out of a total of 102, M. pneumoniae infection occurred throughout all the period evaluated, with 12 and 99 cases, respectively, in December and January.
To select children with M. pneumoniae infection at enrolment, positivity of PCR on throat swab specimen, an approach thought to be highly sensitive and specific was considered. 16, 17 Indeed, lack of antibody response to M. pneumoniae has been noted in both paediatric and adult populations with culture-and/or PCR-positive communityacquired pneumonia 18 and nonspecific stimulus by lipids of other organisms may lead to production of crossreacting antibodies. 14 The diagnosis of M. pneumoniae infection was then confirmed by the presence of elevated serum levels of M. pneumoniae-specific IgM and/or IgG, in the acute phase or their increase in the convalescent phase.
The clinical presentation observed in our patient population did not differ greatly from that described in other studies, 1,2,7 fever and cough being the most common symptoms. Despite the hospital-based nature of our study, the rate of acute dyspnoea and wheezing was lower than recently reported in a similar series. 9 Consistent with the results of this latter study, we found a significant difference in clinical features between the younger and older children with M. pneumoniae infection, dyspnoea, upper respiratory tract involvement, diarrhoea and vomiting being more common in the less than 5 yrs old group than in the other two groups.
A high proportion of children had a chest roentgenograms reported as abnormal, but without pathognomonic features: segmental or patchy consolidation was common in the whole population studied, as in other series, 6, 19 while interstitial changes were more often reported in the youngest group. Pleural effusion was a relatively rare finding and hilar or mediastinal lymphadenopathy was never detected. 6, 19, 20 The observation that the present study was performed on children presenting and admitted to a tertiary children's hospital may also explain the high proportion of cases with clinical and roentgenographic findings consistent with M. pneumoniae-induced pneumonia, as compared with milder manifestations. Finally, preschool-aged children had a higher number of lymphocytes, monocytes and platelets. It is interesting to note that thrombocytosis has been reported only twice in children 9 and in elderly adults. 21 In conclusion, consistent with other studies, these results emphasize the concept that M. pneumoniae should be kept in mind as a cause not only of community-acquired pneumonia, but also of milder respiratory infections in children less than 5 yrs old. Indeed, M. pneumoniae may cause not only pneumonia but also other respiratory syndromes such as bronchitis, bronchiolitis, mimicking viral respiratory infections.
